A single dose of Translate Bio’s first-in-class mRNA therapy MRT5005 may improve lung function in cystic fibrosis, interim Phase 1/2 trial data shows. Click here to read more about it.
What are your thoughts about this study and its findings?
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.OkRead more